Natural history of superficial bladder cancer. Prognostic features and long-term disease course.
about
Novel PKC-ζ to p47 phox interaction is necessary for transformation from blebbishieldsMolecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosisBladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.Update on the management of non-muscle invasive bladder cancer.A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer.Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.Expression profiling for bladder cancer: strategies to uncover prognostic factors.Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladderImproved prognosis assessment for patients with bladder carcinoma.Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms.Oncolytic viruses in the treatment of bladder cancerDevelopment and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder CancersImpact of stage and comorbidities on five-year survival after radical cystectomy in Poland: single centre experience.CUA guidelines on the management of non-muscle invasive bladder cancer.Induction of apoptosis of bladder cancer cells by zinc-citrate compoundGene expression profiling of noninvasive primary urothelial tumours using microarrays.Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.Evaluation of cellular fibronectin plasma levels as a useful staging tool in different stages of transitional cell carcinoma of the bladder and renal cell carcinomaCritical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma.Germline prognostic markers for urinary bladder cancer: obstacles and opportunities.Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of AlbertaGene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.Evaluation of a triple combination of cytokeratin 20, p53 and CD44 for improving detection of urothelial carcinoma in urine cytology specimens.The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancerPositive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancer.microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer.ODF4, MAGEA3, and MAGEB4: Potential Biomarkers in Patients with Transitional Cell Carcinoma.
P2860
Q28116088-DF1CECA7-16C1-4D6E-900F-097CE6F10715Q30439612-BF3E2E65-AC22-4297-B7DE-D061D68BFDC8Q33597980-F477AC7F-992E-4CC0-B51A-E0BDADFFB324Q33613070-99F5DB33-DB09-48F0-8043-15227BD5C6D6Q33640357-2FA85708-972F-4FE3-969E-DB37CF45620EQ33869233-1D0CDAD4-D52D-43CA-802B-940EF6099DD2Q34537170-FA44524A-1910-4EB1-81B2-918C98CDB00EQ35681850-6F389D98-CEA9-431B-BE32-FC9AC64F00C7Q35764857-2B4CFE2B-8C8E-4F44-B1D8-74582DD13542Q35804009-032143B0-DBE8-46AE-BE5A-2D9DF61736F9Q36147934-B800A1E2-0B6A-41E3-8784-AAE556E3ACE6Q36192868-196395E2-3E5A-4869-824D-9DDC72970C74Q36276796-999A6E54-EB95-4539-950B-2FA3D4B66991Q36326208-696AB631-BDBA-43A9-B800-77BDB4D33010Q36413333-CAC0B321-FB5F-4612-A5B1-5644641BDEC5Q36614918-DB7B416A-EEAB-498A-99A6-629C4E6E2043Q36865011-2D1CAE17-34F8-44C5-BD62-7414F9B26934Q37281028-A87D2C97-D953-4BB8-A5DE-BBDE57C4616AQ37284023-E58FA658-43C4-4A1E-90A6-6D2DC0FCE2F3Q37298808-3929E40B-7802-4EEA-8ECE-9DA7335D6745Q38682443-55626577-1ACE-404B-A811-B3F161D4C1E2Q38893600-EC777441-FF6A-4125-A3E5-7587D78A14F4Q41839758-ABE85222-0444-452B-A238-A27328F937ECQ42319480-190AA25B-C902-46F8-B448-C363D32644F5Q43148228-E3F6BBF0-C709-4C89-8F9E-2C38C185ADBAQ43244785-5EFC51C2-C596-45E8-A685-50A49BBC51F1Q55365211-3E9204E6-6C3C-4561-B9E2-4256C653274E
P2860
Natural history of superficial bladder cancer. Prognostic features and long-term disease course.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Natural history of superficial ...... and long-term disease course.
@ast
Natural history of superficial ...... and long-term disease course.
@en
type
label
Natural history of superficial ...... and long-term disease course.
@ast
Natural history of superficial ...... and long-term disease course.
@en
prefLabel
Natural history of superficial ...... and long-term disease course.
@ast
Natural history of superficial ...... and long-term disease course.
@en
P1476
Natural history of superficial ...... and long-term disease course.
@en
P2093
P304
P577
1992-08-01T00:00:00Z